Pulmatrix (PULM) EV to FCF (2014 - 2026)
Pulmatrix's (PULM) quarterly EV to FCF came in at 2.99 in Q2 2026, up 70.93% year-over-year from 1.75 in Q2 2025, and down 364.36% quarter-over-quarter from 0.64 in Q1 2026.
Powered by 
Analysis
Pulmatrix (PULM) EV to FCF (2014 - 2026) Analysis & Trends
Pulmatrix has disclosed EV to FCF across 13 years of filings, most recently posting 2.99 for Q2 2026.
- In Q2 2026, EV to FCF rose 70.93% year-over-year to 2.99; the TTM figure through Jun 2026 stood at 0.85 (up 65.05% YoY), while the FY2025 annual figure was 0.75, up 47.92% from the prior year.
- EV to FCF came in at 2.99 for Q2 2026 at Pulmatrix, down from 0.64 in the prior quarter.
- In the past five years, EV to FCF ranged from a high of 7.6 in Q3 2022 to a low of 12.67 in Q4 2024.
- Average EV to FCF over 5 years is 0.53, with a median of 2.23 recorded in 2024.
- Year-over-year, EV to FCF surged 2385.71% in 2022 and tumbled 1396.01% in 2025.
- Over 5 years, EV to FCF stood at 4.33 in 2022, then surged by 41.45% to 6.12 in 2023, then slumped by 306.98% to 12.67 in 2024, then soared by 54.64% to 5.75 in 2025, then soared by 47.93% to 2.99 in 2026.
- Per Business Quant data, the three most recent EV to FCF figures were 2.99 in Q2 2026, 0.64 in Q1 2026, and 5.75 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Pulmatrix | 5.08 Mn | 5.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.99 |
| Mar 31, 2026 | -0.64 |
| Dec 31, 2025 | -5.75 |
| Sep 30, 2025 | -12.57 |
| Jun 30, 2025 | -10.29 |
| Mar 31, 2025 | -9.23 |
| Dec 31, 2024 | -12.67 |
| Sep 30, 2024 | 0.97 |
| Jun 30, 2024 | 1.76 |
| Mar 31, 2024 | 3.34 |
| Dec 31, 2023 | 6.12 |
| Sep 30, 2023 | 4.38 |
| Jun 30, 2023 | 2.70 |
| Mar 31, 2023 | 3.72 |
| Dec 31, 2022 | 4.33 |
| Sep 30, 2022 | 7.60 |
| Jun 30, 2022 | 5.59 |
| Mar 31, 2022 | 4.05 |
| Dec 31, 2021 | 5.79 |
| Sep 30, 2021 | 2.49 |